Proton and carbon ion radiotherapy for the treatment of prostate cancer is associated with a lower incidence of adverse events than conventional radiotherapy. There are few reports on the quality of life of patients treated with particle therapy, and limited patient-reported outcomes. Analysis of quality of life is important for patients treated with radiotherapy alone or in combination with hormonal therapy, and long-term results, dose fractionation and costs need to be included in the analysis. This information might help both clinical decision-making and selection of appropriate treatments according to the individual needs of patients. This study reviews the literature on the quality of life and outcomes of patients treated with particle therapy, and discusses future directions.
International journal of urology : official journal of the Japanese Urological Association. 2019 Sep 11 [Epub ahead of print]
Hidemasa Kawamura, Nobuteru Kubo, Hiro Sato, Yuhei Miyasaka, Hiroshi Matsui, Kazuto Ito, Kazuhiro Suzuki, Tatsuya Ohno
Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan., Gunma University Heavy Ion Medical Center, Maebashi, Gunma, Japan., Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.